Clinical Report: Shifts in Clinical and Inflammatory Characteristics of Kawasaki Disease

Overview

This study evaluates changes in Kawasaki disease (KD) characteristics during the COVID-19 pandemic, revealing significant alterations in inflammatory markers and clinical presentation.

Background

Kawasaki disease is a significant cause of acquired heart disease in children, characterized by acute vasculitis. The COVID-19 pandemic has impacted the epidemiology of pediatric inflammatory diseases, necessitating an understanding of how KD has evolved during this period. This study provides insights into the clinical and inflammatory characteristics of KD across pre-pandemic, pandemic, and post-pandemic phases.

Data Highlights

Key Findings

• During the pandemic, C-reactive protein and erythrocyte sedimentation rate were significantly higher.
• Thrombocytosis was more frequent during the pandemic period.
• Cervical lymphadenopathy was less common during the pandemic.
• In the post-pandemic period, time to diagnosis was shorter and clinical findings at presentation were more numerous.
• Elevations in liver transaminases were more frequent in the post-pandemic period.
• Rates of intravenous immunoglobulin resistance and coronary artery involvement were similar across all periods.

Clinical Implications

The findings indicate that while the inflammatory characteristics of Kawasaki disease have shifted during the pandemic, the overall cardiac outcomes have not changed significantly.

Conclusion

The study highlights changes in inflammatory markers and presentation of Kawasaki disease during the COVID-19 pandemic.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. American Heart Association, Newsroom, 2024 -- Early detection, intensive treatment critical for high-risk patients with Kawasaki Disease
6. CDC, Case Definitions and Reporting, 2026 -- Case Definitions and Reporting | MIS
7. Author(s)/Org, Source, Year -- Title
8. Early detection, intensive treatment critical for high-risk patients with Kawasaki Disease | American Heart Association
9. Case Definitions and Reporting | MIS | CDC
10. Global incidence of Kawasaki disease: a systematic review